All products
    Medical device · Certification

    Rezpio

    Respiratory monitoring under CE MDR Class IIa

    Rezpio is the medical device track of the platform, under CE MDR Class IIa certification for home and clinical use in asthma and COPD. It pairs voice derived respiratory markers with a clinician facing studio, patient app and the governance, risk and post market surveillance framework required by MDR.

    Class IIa

    Classification

    CE MDR

    Framework

    Asthma · COPD

    Indications

    What you get

    Asthma & COPD

    Monitoring pathways aligned to GINA and GOLD staging.

    Home and clinic

    Patient app for daily checks, clinician studio for review and escalation.

    MDR framework

    Risk management, clinical evaluation and post market surveillance under ISO 13485.

    Clinician workflow

    Trends, alerts and reports designed around respiratory follow up.

    Respiratory clinicsHospitalsHome care providers

    Under CE MDR Class IIa certification. Voice derived estimates.

    Talk to us about Rezpio

    A short form is enough. We will come back with a walkthrough, trial access where it applies, and pricing for your volumes.

    Visit the Rezpio website

    Book a demo or start a free trial

    Tell us a little about your use case. We reply within one business day.

    We only use these details to answer your request.

    ⚠️ Research & Evaluation Use Only: Not for Clinical Use. All voice biomarker values are directional research insights. Not intended for diagnosis or treatment. CE (MDR) certification currently underway. Rezpio is under CE certification for intended use in COPD and Asthma patient management and can currently only be used for research and evaluation purposes.